E-ISSN: 2619-9467

Contents    Cover    Publication Date: 28 Jun 2024
Year 2024 - Volume 34 - Issue 2

Open Access

Peer Reviewed

113 Viewed138 Downloaded

An Evaluation of Maternal Near-Miss Patient Profiles, the Prevalence, Treatment Approach, Outcomes, and Prognostic Factors: A Retrospective Study

Full Text PDF  
JCOG. 2024;34(2):47-54
DOI: 10.5336/jcog.2023-99244
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Objective: The aim of this study was to reduce maternal death rates and contribute to the literature by evaluating maternal near-miss (MNM) profiles, the prevalence, treatment approach, outcomes, and prognostic factors. Material and Methods: A total of 217 MNM patients and 19 cases of maternal death were included in this study. The criteria of organ dysfunction, revised by the World Health Organization (WHO) in 2009, was accepted as the criterion for patients defined as MNM. According to WHO's criteria, the patients were classified in 4 groups. These groups were classified as hypertensive pregnancies, hemorrhagic diseases, placental abruption and disseminated intravascular coagulation and other systemic diseases, respectively. Results: The MNM incidence was 2.31 per 100 live births, and the maternal mortality incidence was 202.4 per 100,000 births. The mortality rate of patients transferred to our hospital because of insufficient intervention at another centre was found to be statistically significantly higher. A statistically significant difference was determined in the laboratory parameters between the MNM cases and patients with maternal mortality in Group 1, 2, and Group 3. The rate of blood and blood products transfusion given to MNM patients was statistically significantly higher in Group 3 than in Group 2. Conclusion: The laboratory parameters found to be significant in MNM and maternal mortality cases could have a negative effect on prognosis and could be of guidance in the prediction of mortality. For patients with an insufficient treatment at other centres, transport to suitable centres would reduce maternal mortality by enabling appropriate interventions.
  1. Chou D, Tunçalp Ö, Firoz T, Barreix M, Filippi V, von Dadelszen P, et al; Maternal Morbidity Working Group. Constructing maternal morbidity-towards a standard tool to measure and monitor maternal health beyond mortality. BMC Pregnancy Childbirth. 2016;16:45. [Crossref]  [PubMed]  [PMC] 
  2. Goldenberg RL, Saleem S, Ali S, Moore JL, Lokangako A, Tshefu A, et al. Maternal near miss in low-resource areas. Int J Gynaecol Obstet. 2017;138(3):347-55. [Crossref]  [PubMed]  [PMC] 
  3. AbouZahar C, Wardlaw T. Maternal Mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. WHO. 2003. Geneva, Switzerland.
  4. Collier AY, Molina RL. Maternal mortality in the united states: updates on trends, causes, and solutions. Neoreviews. 2019;20(10):e561-e74. [Crossref]  [PubMed]  [PMC] 
  5. Nashef SA. What is a near miss? Lancet. 2003;361(9352):180-1. [Crossref]  [PubMed] 
  6. de Pinho da Silva JM, Fonseca SC, Dias MAB, Izzo AS, Teixeira GP, Belfort PP. Concepts, prevalence and characteristics of severe maternal morbidity and near miss in Brazil: a systematic review. Revista Brasileira de Saude Materno Infantil. 2018;18(1):7-35. [Crossref] 
  7. Say L, Souza JP, Pattinson RC; WHO working group on Maternal Mortality and Morbidity classifications. Maternal near miss--towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol. 2009;23(3):287-96. [Crossref]  [PubMed] 
  8. Geller SE, Koch AR, Garland CE, MacDonald EJ, Storey F, Lawton B. A global view of severe maternal morbidity: moving beyond maternal mortality. Reprod Health. 2018;15(Suppl 1):98. [Crossref]  [PubMed]  [PMC] 
  9. Şimşek OY, Yılmaz E, Çelik E, Karaer A, Türkçüoğlu I, Çelik O, et al. Patient profile and treatment outcomes of (near-miss) obstetric patients and evaluation of maternal mortality: a tertiary center experience. Perinatal Journal. 2012;20(1):1-5. [Crossref] 
  10. Yalınkaya A, Özcan Y, Kaya Z, Savaş Z, Erdemoğlu M. Maternal mortality rate in the university hospital. Perinatal Journal. 2008;16(1):9-13. [Link] 
  11. Nakimuli A, Nakubulwa S, Kakaire O, Osinde MO, Mbalinda SN, Nabirye RC, et al. Maternal near misses from two referral hospitals in Uganda: a prospective cohort study on incidence, determinants and prognostic factors. BMC Pregnancy Childbirth. 2016;16:24. [Crossref]  [PubMed]  [PMC] 
  12. Liyew EF, Yalew AW, Afework MF, Essén B. Incidence and causes of maternal near-miss in selected hospitals of Addis Ababa, Ethiopia. PLoS One. 2017;12(6):e0179013. [Crossref]  [PubMed]  [PMC] 
  13. Kiruja J, Osman F, Egal JA, Essén B, Klingberg-Allvin M, Erlandsson K. Maternal near-miss and death incidences - Frequencies, causes and the referral chain in Somaliland: a pilot study using the WHO near-miss approach. Sex Reprod Healthc. 2017;12:30-6. [Crossref]  [PubMed] 
  14. Adamu AN, Okusanya BO, Tukur J, Ashimi AO, Oguntayo OA, Tunau KA, et al. Maternal near-miss and death among women with hypertensive disorders in pregnancy: a secondary analysis of the Nigeria Near-miss and Maternal Death Survey. BJOG. 2019;126 Suppl 3:12-8. [Crossref]  [PubMed] 
  15. Coskun B, Akkurt I, Dur R, Akkurt MO, Ergani SY, Turan OT, et al. Prediction of maternal near-miss in placenta previa: a retrospective analysis from a tertiary center in Ankara, Turkey. J Matern Fetal Neonatal Med. 2018;31(3):370-5. [Crossref]  [PubMed] 
  16. Evsen MS, Sak ME, Soydine HE, Nur CF, Mehmet O, Gul T. Retrospective analysis of placenta accreta: management strategies--evaluation of 41 cases. Ginekol Pol. 2012;83(7):501-4. [PubMed] 
  17. Aslantürk H. Türkiye'de biyo-iktidar açısından sağlık hizmetleri ve kadın [Health services and woman in the terms of Bio-power]. The Journal of Turkish Social Research. 2016;20(3):573-95. [Link]